Glucotrack Prices $3.1M Public Offering
Glucotrack (GCTK) announced the pricing of a public offering involving 0.17 million common shares at $2.04 per share, with certain investors receiving pre-funded warrants for up to 1.35 million additional shares priced at $2.039 each. The company expects gross proceeds from this deal to reach approximately $3.1 million. The offering is set to close around September 25 and was underwritten by Dawson James Securities as the sole placement agent. The pricing of the public offering aligns with Nasdaq market rules, indicating a strategic move aimed at raising capital without significantly diluting existing shareholders. This development comes amid broader investor interest in healthcare stocks, particularly those operating below $2 billion in market cap.
Tickers: $GCTK